Equities

Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)1,480.40
  • Today's Change-3.60 / -0.24%
  • Shares traded38.20k
  • 1 Year change+48.22%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 09:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Jupiter Life Line Hospitals Ltd grew net income 142.25% from 729.04m to 1.77bn primarily through revenue growth (8.93bn to 10.70bn). For while the costs associated with cost of goods, selling, general and administrative and debt all increased as a percentage of sales, the 19.83% growth in revenues contributed enough to still see net income improve.
Gross margin82.00%
Net profit margin15.78%
Operating margin18.64%
Return on assets14.12%
Return on equity15.82%
Return on investment15.75%
More ▼

Cash flow in INRView more

In 2024, Jupiter Life Line Hospitals Ltd increased its cash reserves by 124.04%, or 1.67bn. Cash Flow from Financing totalled 1.28bn or 11.98% of revenues. In addition the company generated 1.15bn in cash from operations while cash used for investing totalled 758.89m.
Cash flow per share34.79
Price/Cash flow per share41.80
Book value per share191.93
Tangible book value per share191.48
More ▼

Balance sheet in INRView more

Jupiter Life Line Hospitals Ltd uses little or no debt in its capital structure.
Current ratio3.34
Quick ratio3.15
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in INR

Year on year, growth in earnings per share excluding extraordinary items increased 157.97%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.